Evidence map›Paper›PMID 42725177›Full record

ArticleBiophotonics discovery2026

Multimodal optical imaging strategy to evaluate the microscopic biodistribution of SERS gold nanoparticles across histology sections.

Boyi Wang, Alexander Czaja, Olga E Eremina, Sean Burkitt, Pegah Bagheri, Helen R Salinas, Fernando Largaespada, Cristina Zavaleta

Abstract read
In one paragraph

Article in Biophotonics discovery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Boyi WangUniversity of Southern California, Department of Biomedical Engineering, Los Angeles, California, United States.ORCID https://orcid.org/0009-0008-2053-7565
Alexander CzajaUniversity of Southern California, Department of Biomedical Engineering, Los Angeles, California, United States.ORCID https://orcid.org/0000-0001-8314-8366
Olga E EreminaUniversity of Southern California, Department of Biomedical Engineering, Los Angeles, California, United States.ORCID https://orcid.org/0000-0002-2776-4743
Sean BurkittUniversity of Southern California, Department of Biomedical Engineering, Los Angeles, California, United States.
Pegah BagheriUniversity of Southern California, Department of Biomedical Engineering, Los Angeles, California, United States.ORCID https://orcid.org/0000-0001-6853-6037
Helen R SalinasUniversity of Southern California, Department of Biomedical Engineering, Los Angeles, California, United States.
Fernando LargaespadaUniversity of Southern California, Department of Biomedical Engineering, Los Angeles, California, United States.
Cristina ZavaletaUniversity of Southern California, Department of Biomedical Engineering, Los Angeles, California, United States.ORCID https://orcid.org/0000-0001-7314-2446

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significance: Surface-enhanced Raman scattering (SERS) gold nanoparticles (AuNPs) are widely used for molecular imaging and diagnostics, but their non-biodegradable nature necessitates accurate, spatially resolved methods to assess long-term biodistribution. Existing approaches often lack sensitivity and spatial resolution or require destructive sample preparation. Aim: We evaluate multiphoton luminescence (MPL) microscopy as a label-free approach for detecting SERS AuNPs in biological tissues while using Raman imaging for spectroscopic validation of nanoparticle (NP) localization. Approach: SERS AuNPs were intravenously administered in mice at multiple doses and analyzed at 1- and 8-week time points using MPL and Raman microscopy. Quantitative analyses were used to compare NP signals across organs, doses, and time points. Results: MPL and Raman imaging both detected SERS AuNP-associated signals across all doses, with strong spatial correlation observed among modalities. Dose-dependent increases in signal were observed for both modalities, with normalized positive pixel area fraction in liver increasing from 0.02 at 0.1 nM to 0.99 at 5 nM. Whole-organ mapping revealed preferential accumulation in the liver and spleen, while longitudinal analysis demonstrated increased NP aggregation at later time points. Conclusions: MPL enables sensitive, label-free detection of SERS AuNPs and, when combined with Raman imaging, provides a non-destructive framework for spatially resolved biodistribution analysis.

Indexed as

biodistributionmultimodal imagingmultiphoton luminescenceRaman spectroscopysurface-enhanced Raman scattering nanoparticles

Identifiers

PMID42725177
PMCPMC13561246

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.